Sanofi is calling for innovative startups and entrepreneurs poised with the mission of improving disease treatments delivery & access to care in Africa.
Your startup has the power to push the boundaries and build solutions beyond medicines while overcoming the bottlenecks in access to health care & treatments.
Participate now, for a chance to build & test your solution in partnership with Sanofi and its subsidiaries.
About Sanofi
Sanofi is an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives.
Our teams across the world strive to transform the practice of medicine, turning the impossible into the possible for patients.
We provide potentially life-changing treatments and the protection of life-saving vaccines to millions of people, and affordable access to our medicines in some of the world’s poorest countries.
Benefits
-
Access coaching and mentoring from Sanofi executives to accelerate your solution development.
-
Initiation of an assessment with Sanofi experts to explore the possibility to partner with us in Africa
-
Invitation to the final event in Cape Town
-
Visibility through ENRICH in Africa and Sanofi Africa main communication channels.
-
A License for the Accelerator Squared online platform.
Requirements
Interview date, Process and Venue
-
March 20, 2023 – Apr 30, 2023: Answer a few questions & submit your 5–10 slides ppt deck to present your solution.
-
May 1, 2023 – May 14, 2023: Projects will be reviewed and selected by Sanofi and ENRICH in Africa partners.
-
June 15, 2023: The 3 finalists will be invited to pitch at the AU-EU innovation festival in Cape Town.
How to Apply
The grand final will take place at the annual AU-EU Innovation Event in Cape Town (South Africa), bringing together key actors from the European and African innovation ecosystem. It is a unique opportunity to earn global exposure and seize amazing networking opportunities.
-
During the event, the 3 finalists will pitch their solution in front of a jury of innovation experts and Sanofi executives.
